Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
Sweeney CJ; Roth BJ; Kabbinavar FF; Vaughn DJ; Arning M; Curiel RE; Obasaju CK; Wang Y; Nicol SJ; Kaufman DS; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2006, vol. 24, issue 21, p 3451, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef